WuXi PharmaTech signs new collaboration agreement with Pfizer
WuXi PharmaTech has announced that it has signed a new three-year, in vitro ADME collaboration agreement with Pfizer.
Pfizer, the US pharmaceuticals group, is in talks to acquire rival Wyeth, a deal that would create new drugs giant with a market value of around $60bn.